Another major healthcare company files Chapter 11 bankruptcy
The developer of products for biopharmaceutical companies and research and academic institutions files for bankruptcy.

The price of biotechnology company financial extinguish filings has been rising over the final two years with companies continuing to file petitions in 2025.
Annual financial extinguish filings had been fewer than 10 each three hundred and sixty five days from 2011 via 2022, but began increasing in 2023 with 14 filings and 13 filings in 2024. Filings in 2023 were one of the best since 2010, when 14 biotech companies filed that three hundred and sixty five days as successfully.
What's Your Reaction?






